Titan Medical Inc. (TMDI)
(Delayed Data from NSDQ)
$2.80 USD
-0.06 (-2.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.79 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.80 USD
-0.06 (-2.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.79 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 23.33% and 3.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 8% and 1.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Titan Medical Inc. (TMDI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Titan Medical Inc. (TMDI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs (MLAB) Q3 Earnings Miss Estimates
by Zacks Equity Research
Mesa Labs (MLAB) delivered earnings and revenue surprises of -19.05% and 13.24%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Titan Medical Inc. (TMDI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Titan Medical Inc. (TMDI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Titan Medical (TMDI) Shows Promise on Strategic Developments
by Zacks Equity Research
Titan Medical (TMDI) is putting in a good deal of effort to strengthen its position in the multi-billion dollar computer-assisted robotic surgical technologies market.